Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,440,855,835    

Indirect Value

   $7,314,725,181      
Total Shares   186,710,189      
Total Value   $9,755,581,016      


Neurocrine Biosciences Inc $682,662,338 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $51,303,423 Ligand Pharmaceuticals Inc $1,290,204,248 Curis Inc $3,390,252 Repligen Corp $412,241,305 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $682,662,338 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $51,303,423 Ligand Pharmaceuticals Inc $1,290,204,248 Curis Inc $3,390,252 Repligen Corp $412,241,305 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-20 4 B $5.00 $218,000 I/I 43,600 4,875,100 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-17 4 B $3.80 $172,900 I/I 45,500 4,854,515 1.5 -
NTII Neurobiological Technolog... Indirect Beneficial Owner   –       –       •   2007-11-06 4 B $2.43 $114,083 I/I 47,000 4,938,393 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-29 4 B $4.99 $236,706 I/I 47,400 3,960,500 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-13 4 B $3.24 $157,305 I/I 48,500 4,428,032 1.5 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-28 4 S $1.85 $90,665 D/D (49,000) 6,019,557 0 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-21 4 S $6.00 $297,000 I/I (49,500) 1,556,351 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-15 4 B $5.08 $252,072 I/I 49,600 7,863,177 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-15 4 B $3.08 $156,983 I/I 51,000 4,487,532 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-11 4 B $3.71 $200,217 I/I 53,900 4,662,115 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-06-28 4 S $5.30 $287,010 I/I (54,000) 1,476,351 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-11-24 4 B $2.45 $133,258 I/I 54,400 5,713,047 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-29 4 B $2.79 $157,632 I/I 56,400 6,182,051 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-10 4 B $0.60 $34,893 I/I 58,300 5,059,299 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-06-29 4 S $2.94 $172,548 D/D (58,616) 15,312,650 0 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-27 4 B $3.12 $201,192 I/I 64,400 4,774,532 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-07-08 4 S $5.00 $334,000 I/I (66,800) 994,851 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-06-29 4 S $5.31 $376,797 I/I (71,000) 1,441,351 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-22 4 B $3.24 $231,372 I/I 71,400 4,577,832 1.5 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-22 4 S $2.77 $199,397 D/D (72,000) 5,874,547 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2009-01-20 4 B $3.08 $231,135 I/I 75,000 5,905,447 1.5 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-29 4 S $2.70 $208,347 D/D (77,100) 5,344,447 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-22 4 B $4.84 $382,313 I/I 79,000 3,419,300 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-18 4 B $1.38 $112,536 I/I 81,400 10,744,709 1.5 -
SGXP Sgx Pharmaceuticals, Inc. Indirect Beneficial Owner   –       –       •   2008-07-08 4 B $2.99 $245,799 I/I 82,100 4,291,674 1.5 -
  195  Records found
  1   2   3   4  5   6   7   8      
  Page 4 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us